Abstract
Corticosteroids are a commonly used modality to address the inflammation associated with chronic rhinosinusitis. Oral corticosteroids deliver a higher concentration of anti-inflammatory to the tissues, but with that comes a higher risk of systemic complication. In this chapter, we review the common side effects of corticosteroids, the data associated with their use, and the current guidelines and expert opinion on their use for specific indications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kaszuba SM, Stewart MG. Medical management and diagnosis of chronic rhinosinusitis: a survey of treatment patterns by United States otolaryngologists. Am J Rhinol. 2006;20:186–90.
Dubin MG, Liu C, Lin SY, Senior BA. American Rhinologic Society member survey on “maximal medical therapy” for chronic rhinosinusitis. Am J Rhinol. 2007;21:483–8.
Hall JE. Adrenocortical hormones. In: Hall JE, editor. Guyton and hall textbook of medical physiology. 12th ed. Philadelphia: Saunders Elsevier; 2011. p. 921–37.
Poetker DM, Reh DD. Complications in the use of systemic steroids for sinusitis. Otolaryngol Clin N Am. 2010;43:753–68.
Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81:1361–7.
Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. J Affect Disord. 1983;5:319–32.
The Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther. 1972;13:694–8.
Kershner P, Wang-Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics. 1989;30:135–9.
Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000;11:478–83.
Allen DB, Bielory L, Derendorf H, Dluhy R, Colice GL, Szefler SJ. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol. 2003;112:S1–40.
Hirsch IB, Paauw DS. Diabetes management in special situations. Endocrinol Metab Clin North Am. 1997;26:631–45.
Chrousos GP. Adrenocorticosteroids & adrenocortical antagonists. In: Katzung BG, editor. Basic & clinical pharmacology. 10th ed. New York: The McGraw-Hill Companies; 2007. p. 635–52.
Segal BH, Sneller MC. Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am. 1997;23:219–37.
Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis. 1989;11:954–63.
Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med. 1994;236:619–32.
McEvoy CE, Niewoehner DE. Adverse effects of corticosteroid therapy for COPD. Chest. 1997;111:732–43.
Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid-induced adverse events in adults. Drug Saf. 2007;30:861–81.
Ganong WF. The adrenal medulla & adrenal cortex. In: Ganong WF, editor. Review of medical physiology. 22nd ed. New York: The McGraw-Hill Companies; 2007. p. 356–81.
Keenan GF. Management of complications of glucocorticoid therapy. Clin Chest Med. 1997;18:507–20.
Ton FN, Gunawardene SC, Lee H, Neer RM. Effects of low-dose prednisone on bone metabolism. J Bone Miner Res. 2005;20:464–70.
van Staa TP, Leufkens HGM, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13:777–87.
Cui Q, Wang G-J, Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J Bone Joint Surg Am. 1997;79-A:1054–63.
Mirzai R, Chang C, Greenspan A, Gershwin ME. The pathogenesis of osteonecrosis and the relationship to corticosteroids. J Asthma. 1999;36:77–95.
McKee MD, Waddell JP, Kudo PA, Schemitsch EH, Richards RR. Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: a report of 15 cases. CMAJ. 2001;164:205–6.
Wong GK, Poon WS, Chiu KH. Steroid-induced avascular necrosis of the hip in neurosurgical patients: epidemiological study. ANZ J Surg. 2005;75:409–10.
Ikeda K, Sakurada T, Suzaki Y, Takasaka T. Efficacy of systemic corticosteroid treatment for anosmia with nasal and paranasal sinus disease. Rhinology. 1995;33:162–5.
Lal D, Scianna JM, Stankiewicz JA. Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure. Am J Rhinol Allergy. 2009;23:396–400.
Subramanian HN, Schechtman KB, Hamilos DL. A retrospective analysis of treatment outcomes and time to relapse after intensive medical treatment for chronic sinusitis. Am J Rhinol. 2002;16:303–12.
Hessler JL, Piccirillo JF, Fang D, et al. Clinical outcomes of chronic rhinosinusitis in response to medical therapy: results of a prospective study. Am J Rhinol. 2007;21:10–8.
Hissaria P, Smith W, Wormald PJ, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006;118:128–33.
Vaidyanathan S, Barnes M, Williamson P, Hopkinson P, Donnan PT, Lipworth B. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: A randomized trial. Ann Intern Med. 2011;154:293–302.
Kirtsreesakul V, Wongsritrang K, Ruttanaphol S. Clinical efficacy of a short course of systemic steroids in nasal polyposis. Rhinology. 2011;49:525–32.
Sieskiewicz A, Olszewska E, Rogowski M, Grycz E. Preoperative corticosteroid oral therapy and intraoperative bleeding during functional endoscopic sinus surgery in patients with severe nasal polyposis: a preliminary investigation. Ann Otol Rhinol Laryngol. 2006;115:490–4.
Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system. Laryngoscope. 2007;117(11 Pt 2 Suppl 115):1–28.
Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, Eisenberg S, et al. Clinical practice guideline: adult sinusitis. Otolarygol Head Neck Surg. 2007;137:S1–31.
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. The european position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;23:1–299.
Poetker DM, Jakubowski LA, Lal D, Hwang PH, Wright ED, Smith TL. Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2013;3:104–20.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Poetker, D.M. (2015). Oral Corticosteroids. In: Batra, P., Han, J. (eds) Practical Medical and Surgical Management of Chronic Rhinosinusitis. Springer, Cham. https://doi.org/10.1007/978-3-319-16724-4_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-16724-4_15
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16723-7
Online ISBN: 978-3-319-16724-4
eBook Packages: MedicineMedicine (R0)